High-Throughput In Vitro ADME Analysis with Agilent RapidFire/MS Systems: Permeability Assays

Significance of the Topic

In early drug discovery, assessing the ability of candidates to cross biological barriers is essential for selecting orally active compounds. Permeability assays such as Caco-2 and PAMPA simulate intestinal uptake, generating large data sets that demand rapid, reliable analytical workflows. Integrating high-throughput mass spectrometry accelerates decision making and resource allocation in lead optimization.

Objectives and Study Overview

This work evaluates the performance of the Agilent RapidFire high-throughput mass spectrometry platform coupled to either a triple quadrupole or time-of-flight detector for in vitro permeability assays. Two main studies compare RapidFire/MS results with conventional liquid chromatography tandem mass spectrometry (LC/MS/MS) in both PAMPA and Caco-2 formats, covering diverse drug candidates and multiple pH conditions.

Applied Instrumentation

• Agilent RapidFire High-throughput Mass Spectrometry System
• Triple quadrupole mass spectrometer
• Time-of-flight high-resolution accurate mass spectrometer

Methodology

PAMPA assays were conducted on 81 proprietary compounds at pH 4, 6.8 and 8.0. RapidFire/TOF analysis used a generic solid phase extraction protocol, processing each sample in under ten seconds. LC/MS/MS required individual multiple reaction monitoring optimization and longer chromatographic cycles. In a second study, permeability coefficients from Caco-2 assays for over 100 compounds were measured by both RapidFire/MS/MS and validated LC/MS/MS workflows.

Main Results and Discussion

Permeability values from RapidFire/TOF correlated strongly with LC/MS/MS data (R2 values between 0.73 and 0.89 across pH conditions). Caco-2 permeability coefficients showed even higher agreement (R2 ~0.97). The RapidFire workflow achieved a ten-fold reduction in analysis time without sacrificing quantitative accuracy or data integrity. Eliminating compound-specific method development further enhanced throughput.

Benefits and Practical Applications

• Significant reduction in sample cycle time and overall assay turnaround
• Elimination of individual MRM optimization accelerates assay setup
• High correlation with gold-standard LC/MS/MS ensures reliable permeability ranking
• Cost and resource savings through streamlined workflows

Future Trends and Opportunities

Advances in automation and robotics may integrate RapidFire platforms into fully unattended ADME screening pipelines. Expanding high-resolution accurate mass detection could enable multiplexed profiling of metabolic stability, protein binding and permeability in a single run. Data analytics and machine learning applied to high-throughput ADME outputs will further refine candidate selection and prediction models.

Conclusion

The Agilent RapidFire system, combined with either QQQ or TOF detection, delivers rapid, robust permeability data that align closely with conventional LC/MS/MS. Its adoption in early drug discovery workflows dramatically increases throughput, reduces costs, and maintains data quality, supporting faster progression of lead compounds.

References

1. Hatsis P et al Reducing Bottlenecks in ADME Sample Analysis using Solid Phase Extraction with a Quadrupole Time-of-Flight Mass Spectrometer Podium talk at the 2010 ASMS meeting
2. Luippold A et al Application of a Rapid and Integrated Analysis System (RIAS) as a High-Throughput Processing Tool for In Vitro ADME Samples by Liquid Chromatography Tandem Mass Spectrometry Journal of Biomolecular Screening 2011 16(3):370-377